Excelsior Biopharma (6496) — Free Cash Flow Generation Index
Excelsior Biopharma (6496) has a Free Cash Flow Generation Index of -2.80x as of June 2025. Free cash flow of NT$-10.64 Million represents -3% of operating cash flow (NT$3.80 Million). Read how much debt does Excelsior Biopharma carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Excelsior Biopharma Free Cash Flow Generation Index (2017–2022)
Historical FCF Generation Index trend for Excelsior Biopharma across 5 annual periods. Explore capital reinvestment ratio of Excelsior Biopharma to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Excelsior Biopharma (2017–2022)
Year-by-year Free Cash Flow Generation Index for Excelsior Biopharma. For the full company profile including market capitalisation, see Excelsior Biopharma market cap and net worth.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -0.42x | NT$-2.30 Million | NT$5.49 Million | NT$7.78 Million | ▼ -144.1% |
| 2021 | 0.95x | NT$52.95 Million | NT$55.82 Million | NT$2.88 Million | ▼ -3.0% |
| 2020 | 0.98x | NT$509.20 Million | NT$520.81 Million | NT$11.62 Million | ▲ +5.7% |
| 2018 | 0.92x | NT$117.38 Million | NT$126.92 Million | NT$9.54 Million | ▼ -2.4% |
| 2017 | 0.95x | NT$331.23 Million | NT$349.47 Million | NT$18.10 Million | — |